|9th January 2017
At the beginning of each year, we take a look at the trends and key topics for healthcare and pharma for the year ahead. In 2017, rather than touch lightly on ‘top trends’ for the year, we’ve taken a deeper dive into an issue that is going to have a profound, lasting impact on the industry: the evolving role of the expert in healthcare.
|3rd April 2020
Decisions made early in the drug development process can define the limits of what’s possible for products and portfolios. So, why aren’t commercial teams always involved in these early conversations? In this Q&A we deep dive into early stage strategy, including how to break down these siloes and rethink drug development and clinical trial design.
|27th March 2020
Senior Associate Consultant, Manos Mastorakis, takes a look at a number of COVID-19 drugs that are already registered in clinical trials, providing analysis aiming to simplify the current landscape.
|6th March 2020
BLH speaks to MM patient advocate, Peter McCleave, to find out how he has fought to remain positive throughout his treatment journey while simultaneously leading a successful campaign to get more people to sign up to be a blood stem cell donor.